Journals / Anadolu Psikiyatri Dergisi / 2018 / Cilt: 19 - Sayı: 1

Evaluation of serum urotensin-II levels of children with ADHD and autism spectrum disorder

DEHB ve otizm spektrum bozukluğu olan çocuklarda serum ürotensin-II düzeylerinin değerlendirilmesi

Pages
80–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with larger sample size could be useful to investigate the role of UII in the etiology and treatment research of ASD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Urotensin-II (U-II) is one of the most vasoconstrictive substrates for the mammals.
📊
Key Findings & Data:Lately, this substrate is thought to be responsible for developing of the neuropsychiatric disorders, by causing an abnormal brain bloodstream situation.
💡
Conclusion & Impact:Further studies with larger sample size could be useful to investigate the role of UII in the etiology and treatment research of ASD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Urotensin-II (U-II) is one of the most vasoconstrictive substrates for the mammals. Lately, this substrate is thought to be responsible for developing of the neuropsychiatric disorders, by causing an abnormal brain bloodstream situation. Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are frequently seen disorders in childhood and their etiologies are remain unclear. This study evaluated the serum urotensin-II levels of children with ASD and ADHD and compared with healthy subjects' urotensin-II levels. Methods: Total of 179 children between age of 4-12, 60 of them diagnosed with ADHD and 60 of children with ASD, according to the DSM-5 criteria and both had no treatment for at least a month and 59 of healthy subjects whom they all admitted to the Ankara Pediatric Hematology-Oncology Training and Research Hospital were included. Schedule for Affective Disorders and Schizophrenia for School-Age Children, a semi-structured interview, was applied to all subjects. Venous samples of the participants were given after a-12 hours starvation. Serum U-II levels were analyzed by the use of ELISA kits. SPSS 16.0 was used for analysis and p<0.05 was accepted as significance level. Results: U-II levels of children with ASD were found higher than that of ADHD and healthy groups. There was also a positive correlation between U-II levels and autism behavior checklist scores. Discussion: Higher U-II levels and its levels' correlation with symptom severity of disorder are thought to be a responsible factor that could play a role in ASD etiology. Further studies with larger sample size could be useful to investigate the role of UII in the etiology and treatment research of ASD.

Özet

Amaç: Ürotensin-II (U-II), bilinen en etkin vazokonstrüktörlerden biridir. Beyin kan akımında oluşturduğu etkilerden dolayı nöropsikiyatrik hastalıkların gelişiminde rol oynadığı düşünülmektedir. Otizm spektrum bozukluğu (OSB) ve dikkat eksikliği hiperaktivite bozukluğu (DEHB) çocukluk çağında sık görülen ve etiyolojileri halen tam olarak bilinemeyen nöropsikiyatrik hastalıklardır. Bu çalışmada OSB ve DEHB'li çocukların serum U-II düzeylerinin değerlendirilmesi ve sağlıklı kontrollerle karşılaştırılması amaçlanmıştır. Yöntem: Ankara Çocuk Hematoloji ve Onkoloji Eğitim ve Araştırma Hastanesi, Çocuk ve Ergen Psikiyatrisi Polikliniği'ne başvuranlar arasından, DSM-5 tanı ölçütlerine göre DEHB ve OSB tanısı konan ve en az bir aydır ilaç kullanmayan 4-12 yaşları arasında 60'ar çocuk ile sağlıklı 59 çocuk çalışmaya alınmıştır. Katılımcılara Okul Çağı Çocukları için Duygulanım Bozuklukları ve Şizofreni Görüşmesi uygulanmıştır. On iki saat açlık sonrası venöz kan örnekleri alınarak ELİSA yöntemi ile serum U-II düzeyi belirlenmiştir. Analizler için SPSS 16.0 kullanılmış, anlamlılık düzeyi p<0.05 olarak belirlenmiştir. Sonuç: DEHB, OSB ve kontrol grupları arasında en yüksek U-II düzeyi OSB grubunda bulunmuştur. Ayrıca OSB'li çocukların belirtilerine yönelik ölçek puanları ile serum U-II düzeyleri arasında pozitif korelasyon bulunmuştur. Tartışma: Kan düzeyinin yüksek olması ve belirti şiddeti ile korelasyon göstermesi, ürotensinin OSB etiyolojisinde rol oynayabileceğini düşündürmüştür. Serum U-II düzeylerinin daha geniş gruplarda değerlendirileceği çalışmalar, otizm etiyolojisi ve tedavi araştırmaları açısından yararlı olabilir.

🔖

Cite This Article

UĞUR, Ç., SERTÇELİK, M., ÜNERİ, Ö. Ş., ŞENSES, G. D., SEKMEN, E., SOLMAZ, E. (2018). Evaluation of serum urotensin-II levels of children with ADHD and autism spectrum disorder. Anadolu Psikiyatri Dergisi, Cilt: 19 - Sayı: 1, 80–86. https://ajindex.com/articles/157460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth ed., Text Revision. Washington, DC: American Psychiatric Association, 2000
  2. Schaefer GB, Mendelsohn NJ. Professional Practice and Guidelines Committee: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 2008; 10:301- 305
  3. Rice C. Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, p.10. Centers for Disease Control and Prevention, 2009
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth ed., Washington, DC: American Psychiatric Association, 1994
  5. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366:237-248
  6. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164:942-948
  7. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol 2005; 71:317-341
  8. Ross BM, McKenzie I, Glen I, Bennett CPW. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 2003; 6:277-281
  9. Onan D, Hannan RD, Thomas WG. Urotensin II: The old kid in town. Trends Endocrinol Metab 2004; 15:175-182
  10. Coulouarn Y, Jégou S, Tostivint H, Vaudry H, Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 1999; 457:28-32
  11. Sturm H, Fernell E, Gillberg C. Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups. Dev Med Child Neurol 2004; 46:444-447
  12. McDonald J, Batuwangala M, Lambert DG. Role of urotensin II and its receptor in health and disease. J Anesth 2007; 21:378-389
  13. Ong KL, Lam KS, Cheung BM. Urotensin II: Its function in health and its role in disease. Cardiovasc Drugs Ther 2005; 19:65-75
  14. Gartlon J, Parker F, David C, Harrison DC, Douglas SA, Ashmeade TE, et al. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 2001; 155:426-433
  15. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, et al. Co-expression of urotensin-II and its receptor (GPR14) in human cardiovascular and renal tissue. J Hypertens 2001